NYSE · Financial Statements

vVARDIS HOLDING AG Class A (VVVV) Revenue, Earnings & Financial Statements

$16.02 NYSE: VVVV Market Cap $328.70M

Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)

Full income statement, balance sheet, and cash flow statement for vVARDIS HOLDING AG Class A (VVVV), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-22.80
FCF Yield—
Quick Ratio0.59
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

vVARDIS HOLDING AG Class A (VVVV) financials — frequently asked questions

What is VVVV EV/EBITDA?

vVARDIS HOLDING AG Class A's enterprise value to EBITDA (EV/EBITDA) ratio is -22.80. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Medical - Specialties stocks

ALC revenue $10.4BSTE revenue $5.9BMLAB revenue $249.0MQDEL revenue $2.7BMOBI stockSI stockMASS revenue $56.0MANIK revenue $113.0MAPYX revenue $53.0MSKIN revenue $301.0MAll Healthcare stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
VVVV Overview VVVV Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.